The Doctors Company Bolsters Board with Healthcare Innovation and Clinical Research Experts
Event summary
- The Doctors Company appointed Akhil Saklecha, MD, MBA, and Owen Garrick, MD, MBA, to its Board of Governors on May 26, 2026.
- Dr. Saklecha brings expertise in healthcare innovation and clinical research, with roles at Danaher and Cleveland Clinic Ventures.
- Dr. Garrick has extensive experience in clinical research and executive leadership, previously serving at Mayo Clinic, CVS Health, and Merck.
- The Board of Governors includes physicians, healthcare leaders, and executives from leading health systems and technology companies.
The big picture
The Doctors Company is strengthening its governance with experts in healthcare innovation and clinical research, reflecting a strategic shift towards integrating cutting-edge advancements into its medical malpractice insurance offerings. This move aligns with broader industry trends where insurers are leveraging technology and research to enhance risk management and service delivery. With over 125,000 healthcare professionals and organizations nationwide, The Doctors Company is positioning itself to better serve the evolving needs of the healthcare sector.
What we're watching
- Innovation Integration
- How Dr. Saklecha's background in healthcare innovation will influence The Doctors Company's strategy and product offerings.
- Clinical Research Focus
- Whether Dr. Garrick's expertise in clinical research will drive new initiatives or partnerships for the company.
- Governance Dynamics
- The pace at which the new board members will impact governance and decision-making processes within The Doctors Company.
Related topics